Patents by Inventor Dilki Wickramarachichi

Dilki Wickramarachichi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of T cells with bispecific antibodies and Fc fusions
    Patent number: 11091548
    Abstract: The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: August 17, 2021
    Assignee: Xencor, Inc.
    Inventors: Matthew Bernett, Seung Chu, Dilki Wickramarachichi, John Desjarlais
  • MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS
    Publication number: 20200339624
    Abstract: The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
    Type: Application
    Filed: December 19, 2019
    Publication date: October 29, 2020
    Inventors: Seung Chu, Matthew Bernett, Dilki Wickramarachichi, John Desjarlais
  • MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS
    Publication number: 20190194325
    Abstract: The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
    Type: Application
    Filed: March 8, 2019
    Publication date: June 27, 2019
    Inventors: Matthew Bernett, Seung Chu, Dilki Wickramarachichi, John Desjarlais
  • Modulation of T cells with bispecific antibodies and FC fusions
    Patent number: 10227411
    Abstract: The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: March 12, 2019
    Assignee: Xencor, Inc.
    Inventors: Matthew Bernett, Seung Chu, Dilki Wickramarachichi, John Desjarlais
  • MODULATION OF T CELLS WITH BISPECIFIC ANTIBODIES AND FC FUSIONS
    Publication number: 20170037131
    Abstract: The present invention relates to methods and compositions for modulating T cells. The modulation includes suppressing or inducing regulatory T cells or cytotoxic T cells.
    Type: Application
    Filed: March 7, 2016
    Publication date: February 9, 2017
    Inventors: Matthew Bernett, Seung Chu, Dilki Wickramarachichi, John Desjarlais